Riskpilot← Back to searchSign inGet full accessEvaran AB
ABActiveOrg 5568758188Grevgatan 4 Nb,Lgh 1001Medical specialists activities · NACE 8622Est. 20111 employees
Revenue 2024
SEK 1,1M
-14% vs 2023
EBITDA margin
61.3%
-14% vs 2023
Equity ratio
95.2%
Financial strength
Net profit 2024
SEK 524K
-13% vs 2023
| Revenue | SEK 1,1M | -14% |
| EBITDA | SEK 661K | -14% |
| Net profit | SEK 524K | -13% |
| Total assets | SEK 1,4M | -1% |
| Equity | SEK 1,3M | +10% |
| Employees | 1 | — |
Legal name
Evaran AB
Org number
5568758188
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 december 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukvårdsverksamhet i privat regi samt därmed förenlig verksamhet.
Address
Grevgatan 4 Nb,Lgh 1001
Email
eva-marie.rane@hlamottagningen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 022 | 1 329 | 1 018 | 1 248 | 1 079 |
| Staff expenses | — | — | −37 | −132 | −33 |
| EBITDA | −50 | 954 | 574 | 764 | 661 |
| Depreciation & amort. | −26 | −18 | −18 | −3 | −3 |
| EBIT | −76 | 936 | 556 | 761 | 657 |
| Net financials | −61 | −32 | −76 | 1 | 2 |
| Profit before tax | −108 | 950 | 480 | 762 | 659 |
| Tax | −0 | −194 | −104 | −157 | −136 |
| Net profit | −108 | 756 | 376 | 605 | 524 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 953 | 1 409 | 1 276 | 1 422 | 1 407 |
| Equity | 979 | 1 135 | 1 011 | 1 216 | 1 339 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | −26 | 274 | 266 | 206 | 67 |
| Total debt | −26 | 274 | 266 | 206 | 67 |
EBITDA margin
61.3%
This company
15.8%
Market median
+288% vs market
20202024
Equity ratio
95.2%
This company
38.2%
Market median
+149% vs market
20202024
Return on equity
39.1%
This company
18.4%
Market median
+113% vs market
20202024
Net profit margin
48.5%
This company
8.1%
Market median
+499% vs market
20202024
Asset turnover
0.77×
This company
1.12×
Market median
-31% vs market
20202024
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Audit | 2021 – 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Evaran AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Olof Anders Johansson Sjödin | Audit | 0 companies |
| Clary Adela Johansson | Deputy Board Member | 0 companies |
| Eva-Marie Rane | Board of Directors | 0 companies |
| Philip August Andreas Rane | Deputy Board Member | 0 companies |